Avid Bioservices Statistics
Total Valuation
CDMO has a market cap or net worth of $425.31 million. The enterprise value is $593.59 million.
| Market Cap | 425.31M |
| Enterprise Value | 593.59M |
Important Dates
The last earnings date was Tuesday, July 2, 2024, after market close.
| Earnings Date | Jul 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CDMO has 63.48 million shares outstanding. The number of shares has decreased by -0.91% in one year.
| Shares Outstanding | 63.48M |
| Shares Change (YoY) | -0.91% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 107.62% |
| Float | 55.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 88.50 |
| PS Ratio | 3.04 |
| Forward PS | 2.76 |
| PB Ratio | 6.99 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 3.39.
| Current Ratio | 1.47 |
| Quick Ratio | 0.78 |
| Debt / Equity | 3.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.21 |
Financial Efficiency
Return on equity (ROE) is -91.60% and return on invested capital (ROIC) is -6.99%.
| Return on Equity (ROE) | -91.60% |
| Return on Assets (ROA) | -33.30% |
| Return on Capital (ROIC) | -6.99% |
| Revenue Per Employee | $383,318 |
| Profits Per Employee | -$385,625 |
| Employee Count | 365 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 3.57 |
Taxes
In the past 12 months, CDMO has paid $113.83 million in taxes.
| Income Tax | 113.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.14% in the last 52 weeks. The beta is 1.51, so CDMO's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -52.14% |
| 50-Day Moving Average | 7.91 |
| 200-Day Moving Average | 7.15 |
| Relative Strength Index (RSI) | 37.71 |
| Average Volume (20 Days) | 1,041,257 |
Short Selling Information
The latest short interest is 15.08 million, so 23.75% of the outstanding shares have been sold short.
| Short Interest | 15.08M |
| Short Previous Month | 11.51M |
| Short % of Shares Out | 23.75% |
| Short % of Float | 27.31% |
| Short Ratio (days to cover) | 17.00 |
Income Statement
In the last 12 months, CDMO had revenue of $139.91 million and -$140.75 million in losses. Loss per share was -$2.23.
| Revenue | 139.91M |
| Gross Profit | 7.32M |
| Operating Income | -18.68M |
| Pretax Income | -26.93M |
| Net Income | -140.75M |
| EBITDA | -11.48M |
| EBIT | -22.59M |
| Loss Per Share | -$2.23 |
Balance Sheet
The company has $38.11 million in cash and $206.38 million in debt, giving a net cash position of -$168.28 million or -$2.65 per share.
| Cash & Cash Equivalents | 38.11M |
| Total Debt | 206.38M |
| Net Cash | -168.28M |
| Net Cash Per Share | -$2.65 |
| Equity (Book Value) | 60.89M |
| Book Value Per Share | 0.96 |
| Working Capital | 33.44M |
Cash Flow
In the last 12 months, operating cash flow was $10.95 million and capital expenditures -$31.81 million, giving a free cash flow of -$20.85 million.
| Operating Cash Flow | 10.95M |
| Capital Expenditures | -31.81M |
| Free Cash Flow | -20.85M |
| FCF Per Share | -$0.33 |
Margins
Gross margin is 5.23%, with operating and profit margins of -13.35% and -100.60%.
| Gross Margin | 5.23% |
| Operating Margin | -13.35% |
| Pretax Margin | -19.25% |
| Profit Margin | -100.60% |
| EBITDA Margin | -8.21% |
| EBIT Margin | -16.15% |
| FCF Margin | -14.90% |
Dividends & Yields
CDMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.91% |
| Shareholder Yield | 0.91% |
| Earnings Yield | -33.09% |
| FCF Yield | -4.90% |
Analyst Forecast
The average price target for CDMO is $12.50, which is 86.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.50 |
| Price Target Difference | 86.57% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 36.26% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 10, 2017. It was a reverse split with a ratio of 1:7.
| Last Split Date | Jul 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
CDMO has an Altman Z-Score of -1.14 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.14 |
| Piotroski F-Score | 3 |